Press release
Healthcare Contract Manufacturing Market to Reach USD 610.9 Billion by 2035, Driven by Biologics Expansion, Emerging Market Outsourcing, and Advanced Manufacturing Technologies
Healthcare Contract Manufacturing Market to Reach USD 610.9 Billion by 2035, Driven by Biologics Expansion, Emerging Market
Growth is powered by rising pharmaceutical outsourcing, the surge in biologics and personalized medicine, and manufacturers' increasing reliance on CMOs (Contract Manufacturing Organizations) to cut costs and streamline operations.
MarketGenics identifies healthcare contract manufacturing as a strategic enabler for pharmaceutical, biologics, and medical device companies, allowing them to focus on innovation and R&D while leveraging specialized partners for large-scale, compliant production.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Healthcare Contract Manufacturing Market Research Report: https://marketgenics.co/press-releases/healthcare-contract-manufacturing-market-31805
Recent Developments Shaping the Market
Johnson & Johnson Expands U.S. Manufacturing Footprint
In August 2025, Johnson & Johnson announced a USD 2 billion investment in a new facility in Holly Springs, North Carolina, in partnership with Fujifilm Diosynth. The facility strengthens domestic production capabilities in response to proposed U.S. pharmaceutical import tariffs.
MSD Reshapes Global Production Strategy
Also in August 2025, MSD (Merck & Co.) revealed plans to shift part of its Keytruda production from Dublin, Ireland, to Wilmington, Delaware. The restructuring aims to save USD 3 billion while reinforcing U.S.-based production capacity amid tariff and policy shifts.
Novo Nordisk Pursues Reshoring Strategy
Novo Nordisk announced the relocation of parts of its diabetes and obesity drug production to the U.S. in 2025, a move designed to de-risk supply chains and ensure domestic drug availability.
Lonza Expands in Asia
In June 2025, Lonza opened a new API (Active Pharmaceutical Ingredient) plant in Hyderabad, India, supporting rising demand in Asian markets and strengthening its role as a global supply chain partner.
Market Forecast 2035
The market is expected to generate an incremental opportunity of USD 418 billion between 2025 and 2035.
Asia Pacific will remain the largest and most attractive region, accounting for 40.3% of global revenue in 2025 (USD 77.9 billion), led by India and China as contract manufacturing hubs.
North America will benefit from reshoring initiatives, tariffs, and large-scale biologics investments.
Europe will see steady demand but will face regulatory complexity and cost pressures.
To know more about the Healthcare Contract Manufacturing Market - Download our Sample Report: https://marketgenics.co/download-report-sample/healthcare-contract-manufacturing-market-31805
Key Drivers, Challenges, and Opportunities
Driver - Rising Demand for Biologics and Personalized Medicine
Biologics, cell therapies, and personalized drugs require advanced, specialized production capabilities. In August 2025, Catalent expanded its Bloomington, Indiana facility with new bioreactors to meet growing biologics demand. Such investments fuel the CMO sector as pharma companies increasingly outsource high-tech manufacturing.
Restraint - Regulatory Compliance Challenges Across Regions
Divergent regulatory frameworks between agencies such as the FDA (U.S.) and EMA (Europe) create costly delays and resource burdens. In July 2025, a leading CMO faced setbacks in device approvals due to documentation inconsistencies, highlighting the risks of fragmented compliance environments.
Opportunity - Expansion into Emerging Markets
Emerging markets present volume-driven growth opportunities. Lonza's Hyderabad API facility and Jubilant Life Sciences' 2025 manufacturing expansion in Gujarat, India, reflect the trend of building scalable, low-cost capacity in Asia to serve global supply chains.
Key Trend - Adoption of Advanced Manufacturing Technologies
AI, automation, and continuous manufacturing are transforming CMO operations. In May 2025, Medtronic deployed AI-driven predictive maintenance, reducing downtime by 15% and boosting productivity by 10%. These technologies are becoming differentiators in securing long-term outsourcing contracts.
Segmental Insights
Pharmaceutical Products Lead with 46% Share
Pharmaceutical products dominate healthcare contract manufacturing due to expanding drug pipelines, chronic disease prevalence, and rising demand for cost-effective outsourced manufacturing. Lonza's 2025 capacity expansion in Switzerland reflects sustained demand for small-molecule and specialty drug production.
Biologics and Biosimilars Gaining Share
The rise of biologics and biosimilars, including monoclonal antibodies and cell therapies, is accelerating demand for specialized CMOs with GMP-certified biologics capacity.
Medical Devices and Diagnostics Growing Steadily
Contract manufacturing in medical devices and diagnostics is also expanding, driven by miniaturization, regulatory compliance needs, and OEMs focusing on innovation.
Buy Now: https://marketgenics.co/buy/healthcare-contract-manufacturing-market-31805
Regional Highlights
Asia Pacific: Market leader with scalable, cost-efficient, high-quality capacity. India and China are central hubs for APIs, finished dosages, and clinical trial supplies.
North America: Benefiting from reshoring, tariff-driven investments, and high biologics adoption.
Europe: Growth steady but challenged by fragmented regulations and cost pressures.
Middle East, Africa, South America: Early-stage but offering opportunities through infrastructure build-outs and government-backed localization programs.
Competitive Landscape
The market is moderately fragmented, with the top five players holding just over 30% of global share in 2025.
Tier 1 Leaders: Catalent, Lonza, FUJIFILM Diosynth, Samsung Biologics, and WuXi AppTec
Tier 2/3 Regional Players: Alcami, Jubilant Pharmova, Delpharm, Famar, and others
Buyer concentration is moderate, as pharma companies can shift between multiple CMOs. Supplier concentration remains higher due to reliance on specialized raw materials and advanced bioprocessing technology.
Future Outlook
By 2035, healthcare contract manufacturing will evolve into a technology-enabled, globally distributed ecosystem where biologics, personalized medicine, and advanced drug delivery systems drive demand. Key growth themes include:
Expansion of biologics and cell/gene therapy outsourcing
Adoption of AI, automation, and continuous manufacturing processes
Supply chain diversification and reshoring strategies in North America and Europe
Rising outsourcing demand in emerging Asia-Pacific and Latin America
The industry's ability to integrate compliance, technology, and cost efficiency will define its role as a critical partner in global healthcare innovation.
Get a preview of our Healthcare Contract Manufacturing Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/healthcare-contract-manufacturing-market-31805
Prominent Companies Operating in the Global Healthcare Contract Manufacturing Market:
Catalent, Lonza Group, FUJIFILM Diosynth, Samsung Biologics, WuXi AppTec, Jubilant Pharmova, Alcami, Delpharm, Famar, and other regional players.
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Healthcare Contract Manufacturing Market to Reach USD 610.9 Billion by 2035, Driven by Biologics Expansion, Emerging Market Outsourcing, and Advanced Manufacturing Technologies here
News-ID: 4204174 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
Intravenous Infusion Pump Market to Reach USD 10.9 Billion by 2035, Driven by Sm …
Intravenous Infusion Pump Market to Reach USD 10.9 Billion by 2035, Driven by Smart Integration and Home Care Expansion
The global Intravenous Infusion Pump Market is projected to grow from USD 5.6 billion in 2025 to USD 10.9 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. Growth is fueled by the rising burden of chronic diseases, the surge in demand for ambulatory and home-based care, and…
Local Anesthesia Drugs Market to Reach USD 5.8 Billion by 2035, Driven by Minima …
The global Local Anesthesia Drugs Market is expected to grow from USD 3.5 Billion in 2025 to USD 5.8 Billion by 2035, expanding at a steady CAGR of 5.1%. Rising surgical volumes, the global push toward non-opioid pain management, and advancements in safer formulations are central to this growth trajectory.
MarketGenics, a leading name in healthcare and pharmaceutical insights, announced a series of milestones in rapidly expanding the global Local Anesthesia…
Medical Adhesive Tapes Market to Reach USD 15.1 Billion by 2035, Driven by Wound …
The global Medical Adhesive Tapes Market is projected to grow from USD 9.2 Billion in 2025 to USD 15.1 Billion by 2035, registering a CAGR of 5.8%. Growth is underpinned by the rising demand for wound care solutions, the rapid expansion of wearable medical devices, and innovation in skin-friendly adhesive technologies.
MarketGenics, a leading name in healthcare and life sciences intelligence, announced a series of milestones in rapidly expanding the global…
Medical Device Cleaning Market to Hit USD 96.1 Billion by 2035, Fueled by Automa …
Medical Device Cleaning Market Set to Reach USD 96.1 Billion by 2035
The global Medical Device Cleaning Market is projected to grow from USD 22.5 Billion in 2025 to USD 96.1 Billion by 2035, expanding at a robust CAGR of 14.1%. This remarkable trajectory reflects the rising global emphasis on infection prevention, patient safety, and compliance with rigorous healthcare standards.
MarketGenics, a leading name in healthcare and life sciences intelligence, announced a…
More Releases for Manufacturing
Manufacturing the Future: Exploring the In-Space Manufacturing Market
Rapid improvements in space technology have created new opportunities for in-space production, transforming the space sector. The in-space manufacturing sector is expanding rapidly as space agencies and private companies investigate ways to manufacture products and structures in space. According to MarketsandMarkets' thorough market research analysis, the worldwide in-space manufacturing market is predicted to expand significantly in the next years. In this blog article, we will evaluate the recent trends and…
Global Miscellaneous Market by Types (Gasket, Packing, and Sealing Device Manufa …
The global Miscellaneous market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Global Miscellaneous Market overview
Miscellaneous Market research report offers great insights into the market and consumer data and their interpretation through various figures and graphs.
Miscellaneous markets have experienced significant growth in recent years. The main reason for this is the increasing…
Smart Factory Transforming from “Manufacturing” to “Intelligent Manufactur …
The concept of “Industry 4.0” was officially announced by the German government in 2013 at the Hannover Messe. Since then, its influence has taken the world by storm. From steam mechanization to power automation to data informatization, the Industry 4.0, driven by “intelligentization”, will completely subvert the expectations, changing perceptions of productivity and production relations in the traditional manufacturing industry by way of qualitative change – an immortal monument, perhaps,…
Additive & Conventional Manufacturing – Hybrid Manufacturing Techniques From C …
Croft Filters, based in Warrington, England, have been supplying custom filtration and separation solutions for over 31 years. Over this time, Croft has developed a reputation for their quality, bespoke service through manufacturing a variety of products for specific requirements. These products have included Filtration Cones, Baskets & Screens, Disc Filters and Filtration Housings amongst others, and they are made with Wire Mesh, Wedge Wire and Perforated Plate, depending on…
Digital Meter Market 2017 - Al-Jon Manufacturing, Environmental Manufacturing, H …
The Global Digital Meter Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Digital Meter industry. First, "Global Digital Meter Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Digital Meter industry chain structure.
Major Companies Covered in this report:-
Al-Jon Manufacturing
Heitman Laboratories
Kws Manufacturing Company
Kmb Systems
Obvius Holdingd Llc
Lubecorp Manufacturing
Quadlogic…
Competitive Segmentation of Global Mixed-mode Manufacturing Market 2016 Industry …
The market research report titled Mixed-mode Manufacturing Market Research Report 2016 provides a detailed overview of the global Mixed-mode Manufacturing market, in terms of crucial market factors such as the demand drivers, challenges, market segments, key companies, and the recent market trends. The quantitative and the qualitative information presented in this research study is based on primary and secondary sources of information. Moreover, much of the information contained in this…
